Forte Biosciences (FBRX) Share-based Compensation (2016 - 2026)
Forte Biosciences (FBRX) recorded Share-based Compensation of $3.67 million in Q2 2026, up 145.2% from $1.5 million a year earlier and up 15.4% from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Share-based Compensation (2016 - 2026) Analysis & Trends
On a TTM basis, Forte Biosciences' Share-based Compensation came in at $9.99 million as of Jun 30, 2026, up 116.9% year-over-year; for FY2025, it was $6.26 million, up 102.2% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 45.6% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $3.1 million in FY2024 (-5.8%), $3.28 million in FY2023 (-18.2%), $4.02 million in FY2022 (-4.7%) and $4.21 million in FY2021 (+340.8%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q1 2016.
- On a year-over-year basis, Share-based Compensation has increased for six consecutive quarters, with growth averaging 80.8% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 292.8% in Q3 2021, against a decline of 38.5% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.18 million (Q1 2026), $1.66 million (Q4 2025) and $1.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | 3.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 697,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Jun 30, 2024 | 802,000.00 |
| Mar 31, 2024 | 805,000.00 |
| Dec 31, 2023 | 780,000.00 |
| Sep 30, 2023 | 772,000.00 |
| Jun 30, 2023 | 855,000.00 |
| Mar 31, 2023 | 877,000.00 |
| Dec 31, 2022 | 860,000.00 |
| Sep 30, 2022 | 906,000.00 |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.47 Mn |
API Access
Forte Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();